Narjust Florez, MD, and Stephanie J. McDonald, MSN, FNP-BC, AOCNP, discuss how care providers help drive treatment adherence in EGFR-mutated NSCLC.
Back
Management and Adherence Strategies in EGFR-Mutated Advanced NSCLC
Narjust Florez, MD, and Stephanie J. McDonald, MSN, FNP-BC, AOCNP, discuss management and adherence strategies in EGFR-mutated non–small cell lung cancer.
Management and Adherence Strategies in EGFR-Mutated Advanced NSCLC
Episodes
All
All
Narjust Florez, MD, and Stephanie J. McDonald, MSN, FNP-BC, AOCNP, discuss initial conversations and methods of support for patients with EGFR-mutated NSCLC.
Narjust Florez, MD, and Stephanie J. McDonald, MSN, FNP-BC, AOCNP, discuss communication strategies between specialists and patients in EGFR-mutated NSCLC management.
Narjust Florez, MD, and Stephanie J. McDonald, MSN, FNP-BC, AOCNP, discuss how nurse practitioners add valuable insight to treatment selection in EGFR-mutated NSCLC.
Narjust Florez, MD, and Stephanie J. McDonald, MSN, FNP-BC, AOCNP, discuss key adverse effects to watch and management strategies in EGFR-mutated NSCLC.
Advertisement
Advertisement
Trending on OncLive
1
Intismeran Autogene Plus Pembrolizumab Meets RFS and DMFS End Points in Resected Stage IIB-IV Melanoma
2
ESMO Guidelines Express Update Recommends Daraxonrasib for RAS G12–Mutated Metastatic PDAC
3
Mo-Rez Advances Into Combination Studies Following Robust Responses in Gynecologic Cancers
4
mRNA Vaccines May Help Increase Long-Term Disease Control in PDAC
5